| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.07e-08 | 11 | 152 | 5 | GO:0005388 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC26A5 NDUFA3 SLC18B1 SLC6A11 SLC6A12 SLC6A13 ATP2C2 SLC4A10 ATP2A1 ATP2A2 ATP2A3 SLC4A5 ATP2B3 | 5.40e-07 | 301 | 152 | 13 | GO:0022853 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA4 SLC26A5 NDUFA3 SLC18B1 ABCA7 SLC26A1 SLC6A11 SLC6A12 SLC6A13 ATP2C2 SLC4A10 ATP2A1 ATP2A2 ATP2A3 SLC4A5 ATP2B3 | 7.62e-07 | 477 | 152 | 16 | GO:0022804 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | GAPVD1 LIMA1 LAMA5 CDH23 CASR LCP1 ITGB1 NRXN3 NRXN2 TJP1 AHNAK CNTN5 ROBO3 CDH1 DHX29 CDH8 VCL | 3.30e-06 | 599 | 152 | 17 | GO:0050839 |
| GeneOntologyMolecularFunction | transporter activity | CACNB1 ABCA4 PLSCR5 ESYT1 SLC26A5 NDUFA3 ATG2A AQP3 SLC18B1 ABCA7 SLC26A1 SLC6A11 SLC6A12 SLC6A13 CLCA1 TRPM3 SLC27A1 ATP2C2 CNGB3 SLC4A10 LRP2 ATP2A1 ATP2A2 ATP2A3 SLC4A5 ATP2B3 | 4.59e-06 | 1289 | 152 | 26 | GO:0005215 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 7.46e-06 | 36 | 152 | 5 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 7.46e-06 | 36 | 152 | 5 | GO:0015662 | |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid:sodium:chloride symporter activity | 8.51e-06 | 6 | 152 | 3 | GO:0005332 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNB1 SLC26A5 NDUFA3 AQP3 SLC18B1 SLC26A1 SLC6A11 SLC6A12 SLC6A13 CLCA1 TRPM3 ATP2C2 SLC4A10 ATP2A1 ATP2A2 ATP2A3 SLC4A5 ATP2B3 | 1.92e-05 | 758 | 152 | 18 | GO:0015318 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.01e-05 | 109 | 152 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | SLC26A5 SLC26A1 SLC6A11 SLC6A12 SLC6A13 CLCA1 SLC4A10 SLC4A5 | 2.08e-05 | 151 | 152 | 8 | GO:0008509 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNB1 SLC26A5 NDUFA3 SLC18B1 SLC26A1 SLC6A11 SLC6A12 SLC6A13 CLCA1 TRPM3 ATP2C2 CNGB3 SLC4A10 ATP2A1 ATP2A2 ATP2A3 SLC4A5 ATP2B3 | 3.48e-05 | 793 | 152 | 18 | GO:0015075 |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid transmembrane transporter activity | 3.51e-05 | 9 | 152 | 3 | GO:0015185 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 4.86e-05 | 125 | 152 | 7 | GO:0015108 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | SLC26A5 SLC26A1 SLC6A11 SLC6A12 SLC6A13 CLCA1 SLC4A10 SLC4A5 | 5.05e-05 | 171 | 152 | 8 | GO:0015103 |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 6.71e-05 | 178 | 152 | 8 | GO:0015399 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNB1 ABCA4 SLC26A5 NDUFA3 AQP3 SLC18B1 ABCA7 SLC26A1 SLC6A11 SLC6A12 SLC6A13 CLCA1 TRPM3 SLC27A1 ATP2C2 CNGB3 SLC4A10 ATP2A1 ATP2A2 ATP2A3 SLC4A5 ATP2B3 | 8.78e-05 | 1180 | 152 | 22 | GO:0022857 |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 9.83e-05 | 32 | 152 | 4 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 9.83e-05 | 32 | 152 | 4 | GO:0005452 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 1.01e-04 | 61 | 152 | 5 | GO:1901682 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 1.09e-04 | 62 | 152 | 5 | GO:0019829 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.59e-04 | 151 | 152 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNB1 NDUFA3 SLC18B1 SLC6A11 SLC6A12 SLC6A13 TRPM3 ATP2C2 CNGB3 SLC4A10 ATP2A1 ATP2A2 ATP2A3 SLC4A5 ATP2B3 | 1.71e-04 | 664 | 152 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | taurine:sodium symporter activity | 1.72e-04 | 3 | 152 | 2 | GO:0005369 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 1.84e-04 | 15 | 152 | 3 | GO:0140161 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNB1 SLC6A11 SLC6A12 SLC6A13 TRPM3 ATP2C2 SLC4A10 ATP2A1 ATP2A2 ATP2A3 SLC4A5 ATP2B3 | 2.37e-04 | 465 | 152 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 2.72e-04 | 17 | 152 | 3 | GO:0015378 | |
| GeneOntologyMolecularFunction | cadherin binding | 2.78e-04 | 339 | 152 | 10 | GO:0045296 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 3.15e-04 | 120 | 152 | 6 | GO:0008013 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNB1 NDUFA3 SLC18B1 SLC6A11 SLC6A12 SLC6A13 TRPM3 ATP2C2 SLC4A10 ATP2A1 ATP2A2 ATP2A3 SLC4A5 ATP2B3 | 3.18e-04 | 627 | 152 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 3.42e-04 | 4 | 152 | 2 | GO:0030899 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 3.83e-04 | 19 | 152 | 3 | GO:0015355 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 3.83e-04 | 19 | 152 | 3 | GO:0015373 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 3.85e-04 | 81 | 152 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | taurine transmembrane transporter activity | 5.67e-04 | 5 | 152 | 2 | GO:0005368 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 5.67e-04 | 5 | 152 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 6.85e-04 | 23 | 152 | 3 | GO:0015377 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 6.85e-04 | 23 | 152 | 3 | GO:0005283 | |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 8.46e-04 | 6 | 152 | 2 | GO:0008510 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 9.89e-04 | 26 | 152 | 3 | GO:0015296 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 1.37e-03 | 29 | 152 | 3 | GO:0005416 | |
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 ESYT1 CDHR1 CDH23 CASR LCP1 ITGB1 RAB44 CELSR1 LRP2 CDH1 ATP2A1 ATP2A2 CDH8 | 1.78e-03 | 749 | 152 | 14 | GO:0005509 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC26A5 SLC26A1 SLC6A11 SLC6A12 SLC6A13 SLC27A1 SLC4A10 SLC4A5 | 1.85e-03 | 293 | 152 | 8 | GO:0008514 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC26A5 SLC18B1 SLC26A1 SLC6A11 SLC6A12 SLC6A13 SLC4A10 SLC4A5 | 1.97e-03 | 296 | 152 | 8 | GO:0015291 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.18e-03 | 119 | 152 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | amino acid binding | 2.34e-03 | 73 | 152 | 4 | GO:0016597 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 2.37e-03 | 35 | 152 | 3 | GO:0005343 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 2.46e-03 | 74 | 152 | 4 | GO:0005548 | |
| GeneOntologyMolecularFunction | oxalate transmembrane transporter activity | 2.49e-03 | 10 | 152 | 2 | GO:0019531 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on diphenols and related substances as donors | 3.03e-03 | 11 | 152 | 2 | GO:0016679 | |
| GeneOntologyMolecularFunction | secondary active sulfate transmembrane transporter activity | 3.03e-03 | 11 | 152 | 2 | GO:0008271 | |
| GeneOntologyMolecularFunction | alpha-catenin binding | 3.61e-03 | 12 | 152 | 2 | GO:0045294 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.93e-03 | 196 | 152 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | antiporter activity | 4.12e-03 | 138 | 152 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 4.25e-03 | 13 | 152 | 2 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 4.25e-03 | 13 | 152 | 2 | GO:0140829 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 4.25e-03 | 13 | 152 | 2 | GO:0140410 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 4.97e-03 | 90 | 152 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 5.12e-03 | 207 | 152 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 5.24e-03 | 208 | 152 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DENND5B GAPVD1 KALRN ARHGAP30 CHM CHML TBC1D17 DENND4B IQSEC1 ARHGEF26 | 5.53e-03 | 507 | 152 | 10 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DENND5B GAPVD1 KALRN ARHGAP30 CHM CHML TBC1D17 DENND4B IQSEC1 ARHGEF26 | 5.53e-03 | 507 | 152 | 10 | GO:0030695 |
| GeneOntologyMolecularFunction | S100 protein binding | 5.66e-03 | 15 | 152 | 2 | GO:0044548 | |
| GeneOntologyMolecularFunction | symporter activity | 5.85e-03 | 150 | 152 | 5 | GO:0015293 | |
| GeneOntologyBiologicalProcess | amino acid neurotransmitter reuptake | 5.03e-07 | 10 | 147 | 4 | GO:0051933 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid reuptake | 1.41e-06 | 4 | 147 | 3 | GO:0051936 | |
| GeneOntologyBiologicalProcess | neurotransmitter reuptake | 7.13e-06 | 38 | 147 | 5 | GO:0098810 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | HSPG2 ISLR2 KALRN CDHR1 LAMA2 LAMA5 CDH23 APLP1 ITGB1 NRXN3 CNTN5 LRP2 COBL ROBO3 CDH1 VCL STRCP1 | 2.49e-05 | 748 | 147 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 3.41e-05 | 52 | 147 | 5 | GO:0001504 | |
| GeneOntologyBiologicalProcess | calcium ion transport from cytosol to endoplasmic reticulum | 5.05e-05 | 2 | 147 | 2 | GO:1903515 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 5.12e-05 | 29 | 147 | 4 | GO:1903779 | |
| GeneOntologyBiologicalProcess | axonogenesis | HSPG2 ISLR2 KALRN LAMA2 LAMA5 APLP1 ITGB1 NRXN3 CNTN5 LRP2 COBL ROBO3 CDH1 VCL | 5.50e-05 | 566 | 147 | 14 | GO:0007409 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 5.99e-05 | 187 | 147 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | sensory perception of sound | 8.93e-05 | 198 | 147 | 8 | GO:0007605 | |
| GeneOntologyBiologicalProcess | sulfur compound transport | 1.01e-04 | 65 | 147 | 5 | GO:0072348 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNB1 SLC26A5 CASR ITGB1 SLC18B1 SLC26A1 SLC6A11 SLC6A12 SLC6A13 CLCA1 TRPM3 AHNAK ATP2C2 SLC4A10 ATP2A1 ATP2A2 ATP2A3 SLC4A5 ATP2B3 | 1.15e-04 | 1017 | 147 | 19 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNB1 SLC26A5 CASR ITGB1 SLC18B1 SLC26A1 SLC6A11 SLC6A12 SLC6A13 CLCA1 TRPM3 AHNAK ATP2C2 CNGB3 SLC4A10 ATP2A1 ATP2A2 ATP2A3 SLC4A5 ATP2B3 | 1.30e-04 | 1115 | 147 | 20 | GO:0034220 |
| GeneOntologyBiologicalProcess | positive regulation of endoplasmic reticulum calcium ion concentration | 1.51e-04 | 3 | 147 | 2 | GO:0032470 | |
| GeneOntologyBiologicalProcess | bicarbonate transport | 1.51e-04 | 38 | 147 | 4 | GO:0015701 | |
| GeneOntologyBiologicalProcess | axon development | HSPG2 ISLR2 KALRN LAMA2 LAMA5 APLP1 ITGB1 NRXN3 CNTN5 LRP2 COBL ROBO3 CDH1 VCL | 2.06e-04 | 642 | 147 | 14 | GO:0061564 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNB1 CDH23 CASR ITGB1 SLC18B1 SLC6A11 SLC6A12 SLC6A13 CLCA1 TRPM3 AHNAK ATP2C2 CNGB3 SLC4A10 LRP2 ATP2A1 ATP2A2 ATP2A3 SLC4A5 ATP2B3 | 2.12e-04 | 1157 | 147 | 20 | GO:0006812 |
| GeneOntologyBiologicalProcess | maintenance of blood-brain barrier | 2.25e-04 | 42 | 147 | 4 | GO:0035633 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNB1 CDH23 CASR ITGB1 SLC6A11 SLC6A12 SLC6A13 CLCA1 TRPM3 AHNAK ATP2C2 SLC4A10 LRP2 ATP2A1 ATP2A2 ATP2A3 SLC4A5 ATP2B3 | 2.77e-04 | 1000 | 147 | 18 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNB1 SLC26A5 CDH23 CASR ITGB1 SLC18B1 SLC26A1 SLC6A11 SLC6A12 SLC6A13 CLCA1 TRPM3 AHNAK ATP2C2 CNGB3 SLC4A10 LRP2 ATP2A1 ATP2A2 ATP2A3 SLC4A5 ATP2B3 | 2.94e-04 | 1374 | 147 | 22 | GO:0006811 |
| GeneOntologyBiologicalProcess | neuroligin clustering involved in postsynaptic membrane assembly | 3.00e-04 | 4 | 147 | 2 | GO:0097118 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 3.14e-04 | 238 | 147 | 8 | GO:0050954 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | HSPG2 ISLR2 KALRN CDHR1 SLC26A5 LAMA2 LAMA5 CDH23 APLP1 ITGB1 NRXN3 CNTN5 LRP2 COBL ROBO3 ARHGEF26 CDH1 CDH8 VCL STRCP1 | 3.20e-04 | 1194 | 147 | 20 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 4.20e-04 | 313 | 147 | 9 | GO:0098742 | |
| GeneOntologyCellularComponent | basal plasma membrane | SLC26A5 CASR AQP3 SLC26A1 SLC6A12 SLC6A13 TJP1 SLC27A1 ATP2C2 SLC4A10 CDH1 SLC4A5 ALPK2 | 2.00e-06 | 354 | 152 | 13 | GO:0009925 |
| GeneOntologyCellularComponent | basolateral plasma membrane | SLC26A5 CASR AQP3 SLC26A1 SLC6A12 SLC6A13 TJP1 ATP2C2 SLC4A10 CDH1 SLC4A5 ALPK2 | 4.05e-06 | 320 | 152 | 12 | GO:0016323 |
| GeneOntologyCellularComponent | basal part of cell | SLC26A5 CASR AQP3 SLC26A1 SLC6A12 SLC6A13 TJP1 SLC27A1 ATP2C2 SLC4A10 CDH1 SLC4A5 ALPK2 | 4.09e-06 | 378 | 152 | 13 | GO:0045178 |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 3.07e-05 | 9 | 152 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 5.96e-05 | 11 | 152 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | synaptic cleft | 9.33e-05 | 33 | 152 | 4 | GO:0043083 | |
| GeneOntologyCellularComponent | basement membrane | 2.71e-04 | 122 | 152 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | Rab-protein geranylgeranyltransferase complex | 3.12e-04 | 4 | 152 | 2 | GO:0005968 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 5.03e-04 | 137 | 152 | 6 | GO:0019897 | |
| GeneOntologyCellularComponent | stereocilium tip | 5.24e-04 | 22 | 152 | 3 | GO:0032426 | |
| GeneOntologyCellularComponent | non-motile cilium | 5.89e-04 | 196 | 152 | 7 | GO:0097730 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 6.21e-04 | 94 | 152 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | presynapse | CACNB1 KALRN CASR SLC18B1 SLC6A11 SLC6A12 SLC6A13 NRXN3 NRXN2 CNTN5 IQSEC1 SLC4A10 CTBP1 CDH1 ATP2B3 CDH8 | 7.44e-04 | 886 | 152 | 16 | GO:0098793 |
| GeneOntologyCellularComponent | ruffle | 7.90e-04 | 206 | 152 | 7 | GO:0001726 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.29e-03 | 164 | 152 | 6 | GO:0098982 | |
| GeneOntologyCellularComponent | photoreceptor outer segment | 1.31e-03 | 111 | 152 | 5 | GO:0001750 | |
| GeneOntologyCellularComponent | neuromuscular junction | 1.37e-03 | 112 | 152 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.48e-03 | 114 | 152 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.50e-03 | 230 | 152 | 7 | GO:0019898 | |
| GeneOntologyCellularComponent | intercalated disc | 1.52e-03 | 68 | 152 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | catenin complex | 1.60e-03 | 32 | 152 | 3 | GO:0016342 | |
| GeneOntologyCellularComponent | anchoring junction | NPM1 HSPG2 LIMA1 LCP1 AQP3 ITGB1 PRX MAGI2 PARD6A TJP1 CD99 AHNAK CDH1 ATP2A2 CDH8 VCL | 2.02e-03 | 976 | 152 | 16 | GO:0070161 |
| Domain | LAM_G_DOMAIN | 1.67e-08 | 38 | 147 | 7 | PS50025 | |
| Domain | Laminin_G_2 | 2.43e-08 | 40 | 147 | 7 | PF02210 | |
| Domain | LamG | 4.87e-08 | 44 | 147 | 7 | SM00282 | |
| Domain | ATPase_P-typ_TM_dom | 1.15e-07 | 16 | 147 | 5 | IPR023298 | |
| Domain | - | 1.15e-07 | 16 | 147 | 5 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.62e-07 | 17 | 147 | 5 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.62e-07 | 17 | 147 | 5 | PF00689 | |
| Domain | Cation_ATPase_N | 2.23e-07 | 18 | 147 | 5 | PF00690 | |
| Domain | Cation_ATPase_N | 2.23e-07 | 18 | 147 | 5 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 3.00e-07 | 19 | 147 | 5 | IPR004014 | |
| Domain | Laminin_G | 3.48e-07 | 58 | 147 | 7 | IPR001791 | |
| Domain | P-type_ATPase_IIA | 4.78e-07 | 3 | 147 | 3 | IPR005782 | |
| Domain | Hydrolase_3 | 7.46e-07 | 10 | 147 | 4 | PF08282 | |
| Domain | ConA-like_dom | HSPG2 LAMA2 LAMA4 LAMA5 BTN3A1 BTN2A1 BTN3A3 CELSR1 NRXN3 NRXN2 ADGRD2 | 1.31e-06 | 219 | 147 | 11 | IPR013320 |
| Domain | EGF_LAM_2 | 3.43e-06 | 30 | 147 | 5 | PS50027 | |
| Domain | EGF_LAM_1 | 3.43e-06 | 30 | 147 | 5 | PS01248 | |
| Domain | Laminin_domII | 4.72e-06 | 5 | 147 | 3 | IPR010307 | |
| Domain | Laminin_aI | 4.72e-06 | 5 | 147 | 3 | IPR009254 | |
| Domain | Laminin_I | 4.72e-06 | 5 | 147 | 3 | PF06008 | |
| Domain | Laminin_II | 4.72e-06 | 5 | 147 | 3 | PF06009 | |
| Domain | EGF_Lam | 7.57e-06 | 35 | 147 | 5 | SM00180 | |
| Domain | ATPase_P-typ_cyto_domN | 7.57e-06 | 35 | 147 | 5 | IPR023299 | |
| Domain | Laminin_EGF | 7.57e-06 | 35 | 147 | 5 | PF00053 | |
| Domain | ATPase_P-typ_P_site | 8.74e-06 | 36 | 147 | 5 | IPR018303 | |
| Domain | P_typ_ATPase | 8.74e-06 | 36 | 147 | 5 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 8.74e-06 | 36 | 147 | 5 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.00e-05 | 37 | 147 | 5 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.00e-05 | 37 | 147 | 5 | PF00122 | |
| Domain | - | 1.00e-05 | 95 | 147 | 7 | 2.60.120.200 | |
| Domain | Laminin_EGF | 1.15e-05 | 38 | 147 | 5 | IPR002049 | |
| Domain | Syndecan | 1.63e-05 | 7 | 147 | 3 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 1.63e-05 | 7 | 147 | 3 | IPR027789 | |
| Domain | LAMININ_IVA | 2.60e-05 | 8 | 147 | 3 | PS51115 | |
| Domain | Laminin_B | 2.60e-05 | 8 | 147 | 3 | PF00052 | |
| Domain | LamB | 2.60e-05 | 8 | 147 | 3 | SM00281 | |
| Domain | Laminin_IV | 2.60e-05 | 8 | 147 | 3 | IPR000034 | |
| Domain | HAD-like_dom | 3.72e-05 | 79 | 147 | 6 | IPR023214 | |
| Domain | Rab_escort | 6.15e-05 | 2 | 147 | 2 | IPR001738 | |
| Domain | IG | HSPG2 ISLR2 KALRN BTN3A2 BTN3A1 BTN2A1 VSTM4 BTN3A3 CILP2 CNTN5 ROBO3 ALPK2 | 1.27e-04 | 421 | 147 | 12 | SM00409 |
| Domain | Ig_sub | HSPG2 ISLR2 KALRN BTN3A2 BTN3A1 BTN2A1 VSTM4 BTN3A3 CILP2 CNTN5 ROBO3 ALPK2 | 1.27e-04 | 421 | 147 | 12 | IPR003599 |
| Domain | Neurexin-like | 1.63e-04 | 14 | 147 | 3 | IPR003585 | |
| Domain | 4.1m | 1.63e-04 | 14 | 147 | 3 | SM00294 | |
| Domain | Znf_CHHC | 1.84e-04 | 3 | 147 | 2 | IPR012996 | |
| Domain | zf-RNPHF | 1.84e-04 | 3 | 147 | 2 | PF08080 | |
| Domain | EGF_1 | 1.92e-04 | 255 | 147 | 9 | PS00022 | |
| Domain | EGF-like_CS | 2.28e-04 | 261 | 147 | 9 | IPR013032 | |
| Domain | IGv | 3.13e-04 | 75 | 147 | 5 | SM00406 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 3.57e-04 | 18 | 147 | 3 | PS00754 | |
| Domain | GDI | 3.65e-04 | 4 | 147 | 2 | PF00996 | |
| Domain | GDP_dissociation_inhibitor | 3.65e-04 | 4 | 147 | 2 | IPR018203 | |
| Domain | SNF | 4.22e-04 | 19 | 147 | 3 | PF00209 | |
| Domain | Na/ntran_symport | 4.22e-04 | 19 | 147 | 3 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 4.22e-04 | 19 | 147 | 3 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 4.22e-04 | 19 | 147 | 3 | PS50267 | |
| Domain | IG_LIKE | HSPG2 ISLR2 KALRN BTN3A2 BTN3A1 BTN2A1 VSTM4 BTN3A3 CILP2 CNTN5 ROBO3 ALPK2 | 5.16e-04 | 491 | 147 | 12 | PS50835 |
| Domain | EGF | 5.55e-04 | 235 | 147 | 8 | SM00181 | |
| Domain | Na/HCO3_transpt | 6.06e-04 | 5 | 147 | 2 | IPR003024 | |
| Domain | Autophagy-rel_C | 6.06e-04 | 5 | 147 | 2 | IPR015412 | |
| Domain | ATG_C | 6.06e-04 | 5 | 147 | 2 | PF09333 | |
| Domain | Ig-like_dom | HSPG2 ISLR2 KALRN BTN3A2 BTN3A1 BTN2A1 VSTM4 BTN3A3 CILP2 CNTN5 ROBO3 ALPK2 | 6.39e-04 | 503 | 147 | 12 | IPR007110 |
| Domain | - | HSPG2 ISLR2 KALRN PKHD1L1 BTN3A2 BTN3A1 BTN2A1 VSTM4 BTN3A3 CILP2 CNTN5 ROBO3 PHYHIPL ALPK2 | 7.59e-04 | 663 | 147 | 14 | 2.60.40.10 |
| Domain | EGF-like_dom | 8.09e-04 | 249 | 147 | 8 | IPR000742 | |
| Domain | PDZ | 8.80e-04 | 141 | 147 | 6 | PF00595 | |
| Domain | Guanylate_kin | 1.09e-03 | 26 | 147 | 3 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 1.09e-03 | 26 | 147 | 3 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 1.09e-03 | 26 | 147 | 3 | IPR008144 | |
| Domain | GuKc | 1.09e-03 | 26 | 147 | 3 | SM00072 | |
| Domain | PDZ | 1.13e-03 | 148 | 147 | 6 | SM00228 | |
| Domain | - | 1.21e-03 | 150 | 147 | 6 | 2.30.42.10 | |
| Domain | PDZ | 1.25e-03 | 151 | 147 | 6 | PS50106 | |
| Domain | S04_transporter_CS | 1.26e-03 | 7 | 147 | 2 | IPR018045 | |
| Domain | ANION_EXCHANGER_2 | 1.26e-03 | 7 | 147 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 1.26e-03 | 7 | 147 | 2 | PS00219 | |
| Domain | PDZ | 1.30e-03 | 152 | 147 | 6 | IPR001478 | |
| Domain | Ig-like_fold | HSPG2 ISLR2 KALRN PKHD1L1 BTN3A2 BTN3A1 BTN2A1 VSTM4 BTN3A3 CILP2 CNTN5 ROBO3 PHYHIPL ALPK2 | 1.38e-03 | 706 | 147 | 14 | IPR013783 |
| Domain | Chorein_N | 1.67e-03 | 8 | 147 | 2 | PF12624 | |
| Domain | VPS13_N | 1.67e-03 | 8 | 147 | 2 | IPR026854 | |
| Domain | Cadherin_CS | 1.71e-03 | 109 | 147 | 5 | IPR020894 | |
| Domain | CADHERIN_1 | 2.00e-03 | 113 | 147 | 5 | PS00232 | |
| Domain | Cadherin | 2.00e-03 | 113 | 147 | 5 | PF00028 | |
| Domain | - | 2.00e-03 | 32 | 147 | 3 | 3.40.1110.10 | |
| Domain | - | 2.00e-03 | 32 | 147 | 3 | 2.70.150.10 | |
| Domain | CADHERIN_2 | 2.08e-03 | 114 | 147 | 5 | PS50268 | |
| Domain | - | 2.08e-03 | 114 | 147 | 5 | 2.60.40.60 | |
| Domain | - | 2.14e-03 | 9 | 147 | 2 | 3.40.1100.10 | |
| Domain | Sialidases | 2.14e-03 | 9 | 147 | 2 | IPR011040 | |
| Domain | Band3_cytoplasmic_dom | 2.14e-03 | 9 | 147 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 2.14e-03 | 9 | 147 | 2 | PF07565 | |
| Domain | CA | 2.16e-03 | 115 | 147 | 5 | SM00112 | |
| Domain | Cadherin-like | 2.25e-03 | 116 | 147 | 5 | IPR015919 | |
| Domain | Cadherin | 2.42e-03 | 118 | 147 | 5 | IPR002126 | |
| Domain | PTrfase/Anion_transptr | 2.66e-03 | 10 | 147 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 2.66e-03 | 10 | 147 | 2 | IPR003020 | |
| Domain | SLC26A | 2.66e-03 | 10 | 147 | 2 | PS01130 | |
| Domain | HCO3_cotransp | 2.66e-03 | 10 | 147 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 2.66e-03 | 10 | 147 | 2 | IPR011531 | |
| Domain | EGF | 3.21e-03 | 126 | 147 | 5 | PF00008 | |
| Domain | STAS | 3.23e-03 | 11 | 147 | 2 | PS50801 | |
| Domain | STAS | 3.23e-03 | 11 | 147 | 2 | PF01740 | |
| Domain | SLC26A/SulP_fam | 3.23e-03 | 11 | 147 | 2 | IPR001902 | |
| Pathway | REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS | 2.19e-06 | 12 | 118 | 4 | M27738 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.19e-06 | 12 | 118 | 4 | M27326 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 4.38e-06 | 14 | 118 | 4 | MM15052 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.55e-06 | 30 | 118 | 5 | M27216 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 9.50e-06 | 59 | 118 | 6 | M27218 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA4 ESYT1 AQP3 ABCA7 SLC26A1 SLC6A11 SLC6A12 SLC6A13 CLCA1 TRPM3 SLC27A1 ATP2C2 SLC4A10 ATP2A1 ATP2A2 ATP2A3 SLC4A5 ATP2B3 | 1.38e-05 | 681 | 118 | 18 | MM14985 |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA | 3.11e-05 | 8 | 118 | 3 | M47955 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA4 ESYT1 AQP3 ABCA7 SLC26A1 SLC6A11 SLC6A12 SLC6A13 CLCA1 TRPM3 SLC27A1 ATP2C2 SLC4A10 ATP2A1 ATP2A2 ATP2A3 SLC4A5 ATP2B3 | 3.87e-05 | 736 | 118 | 18 | M27287 |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 3.93e-05 | 46 | 118 | 5 | M239 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 7.05e-05 | 27 | 118 | 4 | MM15053 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 7.23e-05 | 84 | 118 | 6 | M7098 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 8.18e-05 | 28 | 118 | 4 | M924 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 9.40e-05 | 55 | 118 | 5 | M971 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.08e-04 | 30 | 118 | 4 | M27772 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.12e-04 | 57 | 118 | 5 | MM15643 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3 | 1.40e-04 | 32 | 118 | 4 | M40041 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.72e-04 | 41 | 118 | 4 | M27778 | |
| Pathway | PID_ECADHERIN_STABILIZATION_PATHWAY | 3.72e-04 | 41 | 118 | 4 | M232 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 4.26e-04 | 18 | 118 | 3 | M614 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.34e-04 | 76 | 118 | 5 | M27219 | |
| Pathway | REACTOME_RAB_REGULATION_OF_TRAFFICKING | 4.65e-04 | 118 | 118 | 6 | MM15589 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 5.02e-04 | 19 | 118 | 3 | M27362 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 5.02e-04 | 19 | 118 | 3 | MM15107 | |
| Pathway | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | 5.02e-04 | 19 | 118 | 3 | MM15523 | |
| Pathway | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | 5.02e-04 | 19 | 118 | 3 | M927 | |
| Pathway | REACTOME_RAB_REGULATION_OF_TRAFFICKING | 5.56e-04 | 122 | 118 | 6 | M27872 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 6.91e-04 | 176 | 118 | 7 | MM15718 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 8.70e-04 | 183 | 118 | 7 | M997 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 8.75e-04 | 133 | 118 | 6 | M16476 | |
| Pathway | REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS | 9.41e-04 | 90 | 118 | 5 | M27779 | |
| Pathway | REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS | 9.89e-04 | 91 | 118 | 5 | MM15518 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.07e-03 | 54 | 118 | 4 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.07e-03 | 54 | 118 | 4 | MM15202 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 1.51e-03 | 100 | 118 | 5 | M27158 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.72e-03 | 103 | 118 | 5 | MM15196 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 KALRN ESYT1 NICN1 LAMA5 ATG2A BCL9 LYST ABCA7 BTN3A2 TBC1D17 CELSR1 TNRC18 AHNAK PAXIP1 PDCD11 COBL ARRDC2 PC ATP2A3 METTL27 FOXK1 | 3.66e-09 | 1105 | 153 | 22 | 35748872 |
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 6.48e-09 | 16 | 153 | 5 | 17948866 | |
| Pubmed | 6.48e-09 | 16 | 153 | 5 | 17601529 | ||
| Pubmed | The cluster of BTN genes in the extended major histocompatibility complex. | 1.25e-08 | 7 | 153 | 4 | 11170752 | |
| Pubmed | 2.27e-08 | 105 | 153 | 8 | 30280653 | ||
| Pubmed | 2.49e-08 | 8 | 153 | 4 | 10951186 | ||
| Pubmed | Schwann cell myelination requires integration of laminin activities. | 2.97e-08 | 21 | 153 | 5 | 22767514 | |
| Pubmed | Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. | 7.41e-08 | 10 | 153 | 4 | 18590826 | |
| Pubmed | Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. | 7.64e-08 | 25 | 153 | 5 | 19373938 | |
| Pubmed | Endothelial basement membrane laminin 511 is essential for shear stress response. | 8.35e-08 | 3 | 153 | 3 | 27940654 | |
| Pubmed | Astrocytic γ-aminobutyric acid (GABA) transporters mediate guanidinoacetate transport in rat brain. | 8.35e-08 | 3 | 153 | 3 | 29175673 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 10364433 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 31882770 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 16410239 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 22767497 | ||
| Pubmed | NPM1 LIMA1 HEATR1 LCP1 TRIP12 LYST HNRNPF PRX YBX2 PDIA6 TNRC18 NRXN3 TJP1 AHNAK SLC27A1 EIF5B CFAP74 DLEC1 CDH1 ATP2A1 ATP2A2 ATP2A3 ATP2B3 | 9.25e-08 | 1442 | 153 | 23 | 35575683 | |
| Pubmed | 1.68e-07 | 29 | 153 | 5 | 15071553 | ||
| Pubmed | 1.73e-07 | 12 | 153 | 4 | 11381080 | ||
| Pubmed | 1.73e-07 | 12 | 153 | 4 | 10433923 | ||
| Pubmed | 1.73e-07 | 12 | 153 | 4 | 16750824 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | LIMA1 SPTLC2 ESYT1 LAMA5 ITGB1 SORCS1 PDIA6 AHNAK PZP CDH1 ATP2A1 ATP2A2 ATP2A3 MVP VCL | 1.96e-07 | 647 | 153 | 15 | 26618866 |
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 2.26e-07 | 195 | 153 | 9 | 17110338 | |
| Pubmed | Beta1 integrins control the formation of cell chains in the adult rostral migratory stream. | 3.33e-07 | 4 | 153 | 3 | 17344408 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 9382921 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 25110346 | ||
| Pubmed | Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2. | 3.33e-07 | 4 | 153 | 3 | 39142074 | |
| Pubmed | The nongastric H+-K+-ATPases: molecular and functional properties. | 3.33e-07 | 4 | 153 | 3 | 10362770 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 8420981 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GAPVD1 LIMA1 BCL9 TRIP12 HNRNPF HNRNPH1 FANCD2 PHC3 PDIA6 BRD8 WDHD1 POP1 IQSEC1 EIF5B ATP2A2 DHX29 | 3.51e-07 | 774 | 153 | 16 | 15302935 |
| Pubmed | NPM1 LIMA1 PNKP ESYT1 ITGB1 TRIP12 HNRNPF HNRNPH1 WDHD1 AHNAK COBL | 3.60e-07 | 340 | 153 | 11 | 24332808 | |
| Pubmed | 4.50e-07 | 35 | 153 | 5 | 18676816 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 4.73e-07 | 15 | 153 | 4 | 12921739 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 4.73e-07 | 15 | 153 | 4 | 15895400 | |
| Pubmed | 4.73e-07 | 15 | 153 | 4 | 21401944 | ||
| Pubmed | Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation. | 6.29e-07 | 16 | 153 | 4 | 21067603 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 6.89e-07 | 38 | 153 | 5 | 30786075 | |
| Pubmed | 8.20e-07 | 17 | 153 | 4 | 21983115 | ||
| Pubmed | Beta1-integrins are critical for cerebellar granule cell precursor proliferation. | 8.20e-07 | 17 | 153 | 4 | 15056720 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 8956109 | ||
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 29093447 | ||
| Pubmed | New mouse models for high resolution and live imaging of planar cell polarity proteins in vivo. | 8.29e-07 | 5 | 153 | 3 | 34463728 | |
| Pubmed | Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney. | 8.29e-07 | 5 | 153 | 3 | 9415429 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 9271224 | ||
| Pubmed | Differential expression of laminin alpha chains during murine tooth development. | 8.29e-07 | 5 | 153 | 3 | 9389447 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 29339503 | ||
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 22896705 | ||
| Pubmed | A 1.1-Mb transcript map of the hereditary hemochromatosis locus. | 1.05e-06 | 18 | 153 | 4 | 9149941 | |
| Pubmed | 1.05e-06 | 18 | 153 | 4 | 32496646 | ||
| Pubmed | NPM1 GAPVD1 HEATR1 LCP1 TRIP12 HNRNPF TJP1 AHNAK POP1 EIF5B PDCD11 ATP2A2 MVP VCL | 1.29e-06 | 653 | 153 | 14 | 22586326 | |
| Pubmed | 1.65e-06 | 20 | 153 | 4 | 19726564 | ||
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 9597096 | ||
| Pubmed | Exome sequencing of index patients with retinal dystrophies as a tool for molecular diagnosis. | 1.65e-06 | 6 | 153 | 3 | 23940504 | |
| Pubmed | A synaptic nidogen: developmental regulation and role of nidogen-2 at the neuromuscular junction. | 1.65e-06 | 6 | 153 | 3 | 18817539 | |
| Pubmed | BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation. | 1.65e-06 | 6 | 153 | 3 | 20208008 | |
| Pubmed | NPM1 LIMA1 LAMA5 LCP1 HNRNPH1 YBX2 PDIA6 TJP1 AHNAK CDH1 ATP2A2 VCL | 1.88e-06 | 488 | 153 | 12 | 31324722 | |
| Pubmed | 2.03e-06 | 21 | 153 | 4 | 23325811 | ||
| Pubmed | 2.03e-06 | 21 | 153 | 4 | 33805532 | ||
| Pubmed | 2.48e-06 | 22 | 153 | 4 | 28890335 | ||
| Pubmed | Sox9 plays multiple roles in the lung epithelium during branching morphogenesis. | 2.79e-06 | 50 | 153 | 5 | 24191021 | |
| Pubmed | Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1. | 2.88e-06 | 7 | 153 | 3 | 24786561 | |
| Pubmed | The primitive endoderm segregates from the epiblast in β1 integrin-deficient early mouse embryos. | 2.88e-06 | 7 | 153 | 3 | 24277939 | |
| Pubmed | 2.88e-06 | 7 | 153 | 3 | 14557481 | ||
| Pubmed | 3.39e-06 | 202 | 153 | 8 | 24639526 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 4.60e-06 | 8 | 153 | 3 | 19033399 | |
| Pubmed | 4.60e-06 | 8 | 153 | 3 | 9852162 | ||
| Pubmed | Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides. | 4.60e-06 | 8 | 153 | 3 | 27923914 | |
| Pubmed | 4.99e-06 | 26 | 153 | 4 | 24742657 | ||
| Pubmed | NPM1 LIMA1 KALRN YJEFN3 HNRNPF HNRNPH1 MAGI2 PDIA6 NWD2 NRXN2 TJP1 SLC27A1 IQSEC1 SLC4A10 CTBP1 PC ATP2A2 DHX29 ATP2B3 VCL | 5.12e-06 | 1431 | 153 | 20 | 37142655 | |
| Pubmed | A collection of cDNAs enriched in upper cortical layers of the embryonic mouse brain. | 6.38e-06 | 59 | 153 | 5 | 15010206 | |
| Pubmed | A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. | 6.88e-06 | 9 | 153 | 3 | 25640239 | |
| Pubmed | 6.88e-06 | 9 | 153 | 3 | 18816447 | ||
| Pubmed | 6.88e-06 | 9 | 153 | 3 | 9882526 | ||
| Pubmed | 6.88e-06 | 9 | 153 | 3 | 19126201 | ||
| Pubmed | HAND2-mediated epithelial maintenance and integrity in cardiac outflow tract morphogenesis. | 7.85e-06 | 29 | 153 | 4 | 31201155 | |
| Pubmed | 7.85e-06 | 29 | 153 | 4 | 22613833 | ||
| Pubmed | 9.03e-06 | 30 | 153 | 4 | 23175628 | ||
| Pubmed | Regulation of cadherin junctions during mouse submandibular gland development. | 9.79e-06 | 10 | 153 | 3 | 12112462 | |
| Pubmed | Tbx1 regulates extracellular matrix-cell interactions in the second heart field. | 9.79e-06 | 10 | 153 | 3 | 31180501 | |
| Pubmed | 9.79e-06 | 10 | 153 | 3 | 26989131 | ||
| Pubmed | 9.79e-06 | 10 | 153 | 3 | 11784026 | ||
| Pubmed | Primary cellular meningeal defects cause neocortical dysplasia and dyslamination. | 9.79e-06 | 10 | 153 | 3 | 20976766 | |
| Pubmed | 9.79e-06 | 10 | 153 | 3 | 9034910 | ||
| Pubmed | Integrin alpha6beta1-laminin interactions regulate early myotome formation in the mouse embryo. | 9.79e-06 | 10 | 153 | 3 | 16554364 | |
| Pubmed | 1.03e-05 | 31 | 153 | 4 | 22274697 | ||
| Pubmed | 1.16e-05 | 239 | 153 | 8 | 26641092 | ||
| Pubmed | Cdx2 regulates endo-lysosomal function and epithelial cell polarity. | 1.33e-05 | 33 | 153 | 4 | 20551175 | |
| Pubmed | Regulation of radial glial survival by signals from the meninges. | 1.34e-05 | 11 | 153 | 3 | 19535581 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 1.34e-05 | 11 | 153 | 3 | 23472759 | |
| Pubmed | Loss of nidogen-1 and -2 results in syndactyly and changes in limb development. | 1.34e-05 | 11 | 153 | 3 | 17023412 | |
| Pubmed | 1.34e-05 | 11 | 153 | 3 | 22479204 | ||
| Pubmed | 1.34e-05 | 11 | 153 | 3 | 12051813 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 1.34e-05 | 11 | 153 | 3 | 21524702 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | NPM1 PNKP ESYT1 HEATR1 TRIP12 HNRNPF TJP1 AHNAK EIF5B CTBP1 DHX29 | 1.40e-05 | 498 | 153 | 11 | 36634849 |
| Pubmed | NPM1 GAPVD1 ESYT1 ITGB1 HNRNPF HNRNPH1 PDIA6 AHNAK EIF5B ARHGEF26 ATP2A2 DHX29 VCL | 1.63e-05 | 708 | 153 | 13 | 39231216 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NPM1 GAPVD1 LIMA1 ESYT1 HEATR1 HNRNPF HNRNPH1 PHC3 PDIA6 TJP1 AHNAK EIF5B PC DHX29 VCL | 1.73e-05 | 934 | 153 | 15 | 33916271 |
| Pubmed | 1.78e-05 | 12 | 153 | 3 | 22072575 | ||
| Pubmed | Expression of laminin receptors in schwann cell differentiation: evidence for distinct roles. | 1.78e-05 | 12 | 153 | 3 | 12843252 | |
| Pubmed | 1.78e-05 | 12 | 153 | 3 | 9396756 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 12556521 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 7512260 | ||
| Cytoband | 19p13.11 | 4.82e-06 | 73 | 153 | 5 | 19p13.11 | |
| GeneFamily | ATPases Ca2+ transporting | 8.97e-10 | 9 | 109 | 5 | 1209 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 1.62e-06 | 15 | 109 | 4 | 458 | |
| GeneFamily | Laminin subunits | 4.51e-05 | 12 | 109 | 3 | 626 | |
| GeneFamily | PDZ domain containing | 3.18e-04 | 152 | 109 | 6 | 1220 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 5.01e-04 | 26 | 109 | 3 | 904 | |
| GeneFamily | Solute carriers | SLC26A5 SLC18B1 SLC26A1 SLC6A11 SLC6A12 SLC6A13 SLC27A1 SLC4A10 SLC4A5 | 6.45e-04 | 395 | 109 | 9 | 752 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.92e-03 | 161 | 109 | 5 | 593 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 3.08e-03 | 163 | 109 | 5 | 590 | |
| GeneFamily | ATP binding cassette subfamily A | 3.13e-03 | 14 | 109 | 2 | 805 | |
| GeneFamily | Cadherin related | 4.62e-03 | 17 | 109 | 2 | 24 | |
| GeneFamily | Immunoglobulin like domain containing | 6.28e-03 | 193 | 109 | 5 | 594 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | HSPG2 ABCA4 SLC26A5 CELSR1 NRXN3 TRPM3 COBL ARHGEF26 CDH1 SDC1 | 1.80e-09 | 198 | 153 | 10 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.99e-09 | 200 | 153 | 10 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-08 | 186 | 153 | 9 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.11e-08 | 199 | 153 | 9 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.25e-08 | 200 | 153 | 9 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.25e-08 | 200 | 153 | 9 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-07 | 177 | 153 | 8 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-07 | 179 | 153 | 8 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-07 | 181 | 153 | 8 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-07 | 184 | 153 | 8 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.61e-07 | 185 | 153 | 8 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.72e-07 | 186 | 153 | 8 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 4.38e-07 | 198 | 153 | 8 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.55e-07 | 199 | 153 | 8 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.72e-07 | 200 | 153 | 8 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.72e-07 | 200 | 153 | 8 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.72e-07 | 200 | 153 | 8 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.72e-07 | 200 | 153 | 8 | 13ec8afea86e4a10599c924871ba4e325b0a8013 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 172 | 153 | 7 | 30916a902c151907745756d14327e24adc34afef | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-06 | 178 | 153 | 7 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 178 | 153 | 7 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 179 | 153 | 7 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-06 | 180 | 153 | 7 | df60970520fba2ac0639faa54096766d07418ca4 | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 3.02e-06 | 180 | 153 | 7 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-06 | 181 | 153 | 7 | e6c78038b14100e0c9c6fe25e8f0b75c02c33549 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-06 | 181 | 153 | 7 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-06 | 181 | 153 | 7 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-06 | 181 | 153 | 7 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-06 | 181 | 153 | 7 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-06 | 183 | 153 | 7 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-06 | 184 | 153 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-06 | 184 | 153 | 7 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-06 | 184 | 153 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.50e-06 | 184 | 153 | 7 | af6522586d012e91241f3e06c60f9d1881e95646 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-06 | 184 | 153 | 7 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-06 | 184 | 153 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 3.50e-06 | 184 | 153 | 7 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-06 | 185 | 153 | 7 | 65dcb0a7ee64990a34a87c167b44497107f035ee | |
| ToppCell | mild-Lymphocytic-Plasmablast|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.76e-06 | 186 | 153 | 7 | 060510c21b1e0889b7a6eeb15821b9e2f03a0f99 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.76e-06 | 186 | 153 | 7 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.76e-06 | 186 | 153 | 7 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.76e-06 | 186 | 153 | 7 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-06 | 186 | 153 | 7 | 02fbb02c495e7d64c4ab50e42e5197782f2c0816 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.89e-06 | 187 | 153 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.89e-06 | 187 | 153 | 7 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 4.17e-06 | 189 | 153 | 7 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | mild-Lymphocytic-Plasmablast|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.17e-06 | 189 | 153 | 7 | db2097e6e165004d47ed504e115083a4e4f4b147 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.32e-06 | 190 | 153 | 7 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.32e-06 | 190 | 153 | 7 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.32e-06 | 190 | 153 | 7 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-06 | 190 | 153 | 7 | edc0a0eb17abbecb0f06d302be3d4f8c1dd4f333 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.32e-06 | 190 | 153 | 7 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.79e-06 | 193 | 153 | 7 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.79e-06 | 193 | 153 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | severe-Plasmablast|World / disease stage, cell group and cell class | 4.95e-06 | 194 | 153 | 7 | 49e8f90db571a89b8a26aef31fcacd66429fed11 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.95e-06 | 194 | 153 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.95e-06 | 194 | 153 | 7 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.95e-06 | 194 | 153 | 7 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | Control-CD8+_Tem|Control / Disease condition and Cell class | 5.12e-06 | 195 | 153 | 7 | 7503b3e032f95b350a2782d28e4d412a8dc9ebcc | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 5.12e-06 | 195 | 153 | 7 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.12e-06 | 195 | 153 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.12e-06 | 195 | 153 | 7 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | severe-Plasmablast|severe / disease stage, cell group and cell class | 5.12e-06 | 195 | 153 | 7 | e11616ad568e50e4c720b50b0c071f484c31d16b | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.12e-06 | 195 | 153 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | lymphoid-T_cell-Regulatory_T_cell|World / Lineage, cell class and subclass | 5.30e-06 | 196 | 153 | 7 | 42a4d706382be33d552ece1d0598d073857a8d4e | |
| ToppCell | Mild/Remission-Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.30e-06 | 196 | 153 | 7 | dcf0a804a79a05454658498d1f87320c7e079219 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.30e-06 | 196 | 153 | 7 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.48e-06 | 197 | 153 | 7 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | T_cells-CTLs|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.48e-06 | 197 | 153 | 7 | 28117cf300e169182571fbad0de1681a484a435a | |
| ToppCell | lymphoid-T_cell-Regulatory_T_cell|lymphoid / Lineage, cell class and subclass | 5.48e-06 | 197 | 153 | 7 | 73d5dcf076caae60ea32258b4e9dcac8979a661e | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 5.48e-06 | 197 | 153 | 7 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.48e-06 | 197 | 153 | 7 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.66e-06 | 198 | 153 | 7 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 5.66e-06 | 198 | 153 | 7 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 5.66e-06 | 198 | 153 | 7 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | (2)_NK/T-(22)_CD8+_T_cell-(220)_CD8+_Cytotoxic_T_cell|(22)_CD8+_T_cell / immune cells in Peripheral Blood (logTPM normalization) | 5.66e-06 | 198 | 153 | 7 | 1bb60688ff0e42471c8b646652fe95b9b28c41a3 | |
| ToppCell | (2)_NK/T-(23)_CD4+_T_cell-(231)_CD4+/CD45RO+_Memory_T_cell|(23)_CD4+_T_cell / immune cells in Peripheral Blood (logTPM normalization) | 5.66e-06 | 198 | 153 | 7 | cd1548fc27779ada721ca00c72ebd3b6c9b15a19 | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.85e-06 | 199 | 153 | 7 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.85e-06 | 199 | 153 | 7 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | proximal-Epithelial-Ciliated|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.85e-06 | 199 | 153 | 7 | 9700f06e51ddca85e482b4f9bd4a79bfcd3cfb76 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial|World / Primary Cells by Cluster | 5.85e-06 | 199 | 153 | 7 | b9763ac9857a60db6f1f104fe1e9ea2266cf931b | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial-24|World / Primary Cells by Cluster | 5.85e-06 | 199 | 153 | 7 | 0b4edf3e359749827ef978a77b5267ddde732d71 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.85e-06 | 199 | 153 | 7 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.85e-06 | 199 | 153 | 7 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial|World / Primary Cells by Cluster | 5.85e-06 | 199 | 153 | 7 | 9e01eee126247a0696c71b019f855a8a41a0ede3 | |
| ToppCell | proximal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.85e-06 | 199 | 153 | 7 | 1188afad6fd5f01f9aeba225f611f38b237dd2c9 | |
| ToppCell | proximal-Epithelial-Ciliated-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.85e-06 | 199 | 153 | 7 | 2e8ace105c4e2405baa06d953e52888b54e2d055 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 6.05e-06 | 200 | 153 | 7 | eac33be484dc443794e66e473f03e98406c2983e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 6.05e-06 | 200 | 153 | 7 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.05e-06 | 200 | 153 | 7 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.05e-06 | 200 | 153 | 7 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.05e-06 | 200 | 153 | 7 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 6.05e-06 | 200 | 153 | 7 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.34e-06 | 135 | 153 | 6 | 7e3559ed0fef7916d1938b4e1a9fa4456a60e3d3 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Agt_(Agt)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.34e-06 | 135 | 153 | 6 | 4cb399620aa9edc2ca59e4df76ab7011ceb58db9 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.34e-06 | 135 | 153 | 6 | 6bd2a0bfd8d20950f1b66810668682dc055a0ada | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Agt_(Agt)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.34e-06 | 135 | 153 | 6 | 97989546826bf3739e1b86a10832a457fd37c5d2 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|blood / Manually curated celltypes from each tissue | 7.65e-06 | 136 | 153 | 6 | f024015bf60e64b8657e410e24995a1edec85196 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 145 | 153 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 1.24e-05 | 148 | 153 | 6 | db046a02a00829910bf9d7dbda068e730aa78f00 | |
| Computational | Neighborhood of CASP8 | 8.96e-05 | 27 | 96 | 4 | GNF2_CASP8 | |
| Drug | AC1L88YH | 8.28e-10 | 17 | 149 | 6 | CID000374551 | |
| Drug | 1sqc | 2.75e-09 | 10 | 149 | 5 | CID000444279 | |
| Drug | 2,5-dimethylquinone | 5.02e-09 | 11 | 149 | 5 | CID000008718 | |
| Drug | 1vyq | 8.56e-09 | 12 | 149 | 5 | CID004369390 | |
| Drug | cyhexatin | 1.13e-08 | 25 | 149 | 6 | CID005364545 | |
| Drug | p-hydroxyhippuric acid | 2.14e-08 | 14 | 149 | 5 | CID000151012 | |
| Drug | toxaphene | 1.01e-07 | 58 | 149 | 7 | CID005284469 | |
| Drug | CC270 | 1.14e-07 | 59 | 149 | 7 | CID006918852 | |
| Drug | lanthanum | 2.85e-07 | 136 | 149 | 9 | CID000023926 | |
| Drug | AC1L25Y6 | 3.43e-07 | 23 | 149 | 5 | CID000015465 | |
| Drug | lanthanum chloride hydrate | 3.43e-07 | 23 | 149 | 5 | CID000165791 | |
| Drug | fluorescein isothiocyanate | 5.52e-07 | 147 | 149 | 9 | CID000018730 | |
| Drug | dodecyl ether | 6.61e-07 | 26 | 149 | 5 | CID000020667 | |
| Drug | epicholesterol | HSPG2 ABCA4 SPTLC2 APLP1 LYST ABCA7 CILP2 BRD8 SLC27A1 ATP2C2 LRP2 ATP2A1 ATP2A2 ATP2A3 MVP ATP2B3 SDC1 | 9.71e-07 | 636 | 149 | 17 | CID000000304 |
| Drug | octaethylene glycol | 1.17e-06 | 29 | 149 | 5 | CID000078798 | |
| Drug | 1,4-dibromobutane | 1.27e-06 | 53 | 149 | 6 | CID000008056 | |
| Drug | sanguinarine | 2.66e-06 | 60 | 149 | 6 | CID000005154 | |
| Drug | fluorescamine | 3.11e-06 | 35 | 149 | 5 | CID000037927 | |
| Drug | mag-fura-2 | 4.13e-06 | 37 | 149 | 5 | CID000123839 | |
| Drug | acotiamide | 4.13e-06 | 37 | 149 | 5 | CID005282338 | |
| Drug | gramicidin s | 4.13e-06 | 37 | 149 | 5 | CID000073357 | |
| Drug | clotrimazole | 4.70e-06 | 143 | 149 | 8 | CID000002812 | |
| Drug | L-beta-aspartyl phosphate | 6.06e-06 | 69 | 149 | 6 | CID000000832 | |
| Drug | carbidine | 6.14e-06 | 40 | 149 | 5 | CID000065684 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HG-U133A | 6.22e-06 | 197 | 149 | 9 | 381_DN | |
| Drug | AC1L380G | 6.33e-06 | 19 | 149 | 4 | CID000084698 | |
| Drug | C12E8 | 7.85e-06 | 42 | 149 | 5 | CID000123921 | |
| Drug | cocaethylene | 8.42e-06 | 73 | 149 | 6 | CID000002825 | |
| Drug | agelasine B | 1.24e-05 | 46 | 149 | 5 | CID006439899 | |
| Drug | vitamin D3 | CYP1A1 TNFSF9 LYST CNTN5 ATP2C2 LRP2 ATP2A1 ATP2A2 ATP2A3 ATP2B3 | 1.49e-05 | 277 | 149 | 10 | CID000002735 |
| Drug | blebbistatin | 1.50e-05 | 8 | 149 | 3 | ctd:C472645 | |
| Drug | AC1L1G0K | 1.70e-05 | 49 | 149 | 5 | CID000003473 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.23e-05 | 177 | 149 | 8 | 5745_UP | |
| Drug | R 8231 | 2.24e-05 | 9 | 149 | 3 | CID003084926 | |
| Drug | AC1L1IZE | 2.53e-05 | 131 | 149 | 7 | CID000004799 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 2.84e-05 | 183 | 149 | 8 | 7550_UP | |
| Drug | AC1MMLID | 3.19e-05 | 92 | 149 | 6 | CID000013245 | |
| Drug | tricyclohexyltin chloride | 3.19e-05 | 10 | 149 | 3 | CID000076539 | |
| Drug | ATP-EDC | 3.19e-05 | 10 | 149 | 3 | CID000195647 | |
| Drug | Shims | 3.19e-05 | 10 | 149 | 3 | CID000194233 | |
| Drug | AC1L1JAO | 3.57e-05 | 57 | 149 | 5 | CID000004955 | |
| Drug | AC1NSKPI | 3.57e-05 | 57 | 149 | 5 | CID005311482 | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 3.85e-05 | 191 | 149 | 8 | 5607_DN | |
| Drug | ethylketocyclazocine | 3.89e-05 | 58 | 149 | 5 | CID000135018 | |
| Drug | nitrous oxide | 4.05e-05 | 96 | 149 | 6 | CID000000948 | |
| Drug | AC1L1G72 | 4.36e-05 | 11 | 149 | 3 | CID000003553 | |
| Drug | bornane | 4.36e-05 | 11 | 149 | 3 | CID000092108 | |
| Drug | persulfate | 4.36e-05 | 11 | 149 | 3 | CID000024413 | |
| Drug | acetyl phosphate | 4.56e-05 | 98 | 149 | 6 | CID000000186 | |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 4.62e-05 | 196 | 149 | 8 | 3536_DN | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; PC3; HT_HG-U133A | 4.62e-05 | 196 | 149 | 8 | 4296_DN | |
| Drug | Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; HL60; HT_HG-U133A | 4.62e-05 | 196 | 149 | 8 | 2381_UP | |
| Drug | Cefotiam hydrochloride; Down 200; 7.2uM; MCF7; HT_HG-U133A | 4.79e-05 | 197 | 149 | 8 | 3319_DN | |
| Drug | Pindolol [13523-86-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 4.79e-05 | 197 | 149 | 8 | 2238_UP | |
| Drug | Phenindione [83-12-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 4.79e-05 | 197 | 149 | 8 | 2868_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 4.79e-05 | 197 | 149 | 8 | 4732_DN | |
| Drug | Lansoprazole [103577-45-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 4.79e-05 | 197 | 149 | 8 | 6009_UP | |
| Drug | indo-1 | 4.82e-05 | 99 | 149 | 6 | CID000105060 | |
| Drug | nimodipine | 4.85e-05 | 145 | 149 | 7 | CID000004497 | |
| Drug | estradiol, USP; Up 200; 0.1uM; PC3; HT_HG-U133A | 4.96e-05 | 198 | 149 | 8 | 4432_UP | |
| Drug | Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; HL60; HT_HG-U133A | 4.96e-05 | 198 | 149 | 8 | 2173_UP | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 4.96e-05 | 198 | 149 | 8 | 1503_DN | |
| Drug | Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; HL60; HT_HG-U133A | 5.14e-05 | 199 | 149 | 8 | 3140_DN | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; PC3; HG-U133A | 5.14e-05 | 199 | 149 | 8 | 1888_UP | |
| Drug | magnesium | DNAH3 PNKP LAMA2 LAMA4 LAMA5 CASR IDI2 RILP CHM AQP3 ITGB1 AK7 TRPM3 ATP2C2 POP1 EIF5B PC CDH1 ATP2A1 ATP2A2 ATP2A3 ATP2B3 | 5.22e-05 | 1325 | 149 | 22 | CID000000888 |
| Drug | AC1NS1NG | 5.29e-05 | 147 | 149 | 7 | CID005327099 | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; PC3; HT_HG-U133A | 5.33e-05 | 200 | 149 | 8 | 4588_UP | |
| Drug | FCCP | 5.40e-05 | 101 | 149 | 6 | CID000003330 | |
| Drug | I Tax | 5.79e-05 | 12 | 149 | 3 | CID000003792 | |
| Drug | dithionite | 6.01e-05 | 150 | 149 | 7 | CID000001086 | |
| Drug | milrinone | 6.01e-05 | 150 | 149 | 7 | CID000004197 | |
| Drug | C13932 | 6.56e-05 | 206 | 149 | 8 | CID000168297 | |
| Drug | I-Q-S | 7.70e-05 | 156 | 149 | 7 | CID000003540 | |
| Drug | CaCl2 | 7.70e-05 | 156 | 149 | 7 | CID000024854 | |
| Drug | chlordecone | 7.82e-05 | 67 | 149 | 5 | CID000000299 | |
| Drug | succinate | GPR162 AK7 FANCD2 NRXN2 ATP2C2 PC ATP2A1 ATP2A2 ATP2A3 ATP2B3 | 8.23e-05 | 339 | 149 | 10 | CID000001110 |
| Drug | oxalate | 8.34e-05 | 158 | 149 | 7 | CID000000971 | |
| Drug | strontium | 8.39e-05 | 68 | 149 | 5 | CID000104798 | |
| Drug | Phosphoryl | 8.84e-05 | 215 | 149 | 8 | CID006857426 | |
| Drug | tBuBHQ | 9.00e-05 | 69 | 149 | 5 | CID000002374 | |
| Drug | caged ATP | 9.64e-05 | 70 | 149 | 5 | CID000123806 | |
| Drug | Pyrethroids | 1.03e-04 | 71 | 149 | 5 | CID000005053 | |
| Drug | Calcort | 1.09e-04 | 38 | 149 | 4 | CID000026709 | |
| Drug | monobromobimane | 1.10e-04 | 72 | 149 | 5 | CID000114810 | |
| Drug | NSC239129 | 1.18e-04 | 15 | 149 | 3 | CID000084597 | |
| Drug | NSC381866 | 1.27e-04 | 169 | 149 | 7 | CID000002287 | |
| Drug | ASPAN | 1.27e-04 | 3 | 149 | 2 | CID005475577 | |
| Drug | Gaba-Glu | 1.27e-04 | 3 | 149 | 2 | CID000129795 | |
| Drug | 2,3,6,7-tetrachlorobiphenylene | 1.27e-04 | 3 | 149 | 2 | CID000081533 | |
| Drug | AC1L1IIA | 1.42e-04 | 172 | 149 | 7 | CID000004591 | |
| Drug | 2-amino-5-methylpyridine | 1.52e-04 | 77 | 149 | 5 | CID000015348 | |
| Drug | fluo-3 | 1.54e-04 | 122 | 149 | 6 | CID000104978 | |
| Drug | sodium | BCL9 AQP3 SLC26A1 SLC6A11 SLC6A12 SLC6A13 CLCA1 TRPM3 TJP1 ATP2C2 LRP2 ATP2A1 ATP2A2 ATP2A3 SLC4A5 ATP2B3 ALPK2 | 1.54e-04 | 944 | 149 | 17 | CID000000923 |
| Drug | 3-(1H-pyrrole-2-carboxylate | 1.54e-04 | 233 | 149 | 8 | CID000005114 | |
| Drug | 2-butenedioate | 1.59e-04 | 234 | 149 | 8 | CID000000723 | |
| Drug | Les T | 1.61e-04 | 123 | 149 | 6 | CID000003189 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.63e-04 | 176 | 149 | 7 | 4565_UP | |
| Drug | YIGSR | 1.71e-04 | 79 | 149 | 5 | CID000123977 | |
| Drug | 5'-pCAA-3' | 1.83e-04 | 126 | 149 | 6 | CID000482140 | |
| Drug | phosphocreatine disodium | 1.83e-04 | 126 | 149 | 6 | CID000000587 | |
| Disease | Brody myopathy (implicated_via_orthology) | 1.24e-07 | 3 | 148 | 3 | DOID:0050692 (implicated_via_orthology) | |
| Disease | Juvenile macular degeneration | 2.50e-05 | 2 | 148 | 2 | C4282180 | |
| Disease | choroideremia (implicated_via_orthology) | 2.50e-05 | 2 | 148 | 2 | DOID:9821 (implicated_via_orthology) | |
| Disease | alpha-L-iduronidase measurement | 7.99e-05 | 17 | 148 | 3 | EFO_0020139 | |
| Disease | hydrocephalus (implicated_via_orthology) | 1.13e-04 | 19 | 148 | 3 | DOID:10908 (implicated_via_orthology) | |
| Disease | calcium oxalate nephrolithiasis (is_implicated_in) | 2.47e-04 | 5 | 148 | 2 | DOID:0080652 (is_implicated_in) | |
| Disease | STARGARDT DISEASE 1 (disorder) | 2.47e-04 | 5 | 148 | 2 | C1855465 | |
| Disease | caudate volume change measurement, age at assessment | 3.31e-04 | 27 | 148 | 3 | EFO_0008007, EFO_0021491 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 3.70e-04 | 6 | 148 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | normal | 3.70e-04 | 6 | 148 | 2 | PATO_0000461 | |
| Disease | Stargardt's disease | 3.70e-04 | 6 | 148 | 2 | C0271093 | |
| Disease | Primary familial dilated cardiomyopathy | 4.55e-04 | 30 | 148 | 3 | cv:C0340427 | |
| Disease | non-small cell lung carcinoma | 5.60e-04 | 75 | 148 | 4 | EFO_0003060 | |
| Disease | Primary dilated cardiomyopathy | 6.60e-04 | 34 | 148 | 3 | cv:C0007193 | |
| Disease | helix rolling | 6.86e-04 | 8 | 148 | 2 | EFO_0007670 | |
| Disease | Disorder of eye | 7.24e-04 | 212 | 148 | 6 | C0015397 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 8.59e-04 | 84 | 148 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | heart disease (implicated_via_orthology) | 9.17e-04 | 38 | 148 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | CYP1A1 ABCA4 KALRN ETS2 LAMA2 NDUFA3 BTN3A2 SORCS1 OSTC POP1 DLEC1 CDH1 ATP2A3 VPS13B | 1.05e-03 | 1074 | 148 | 14 | C0006142 |
| Disease | spleen volume | 1.32e-03 | 43 | 148 | 3 | EFO_0600047 | |
| Disease | Familial dilated cardiomyopathy | 1.41e-03 | 44 | 148 | 3 | C0340427 | |
| Disease | platelet component distribution width | CYP1A1 GAPVD1 KALRN LAMA5 LCP1 VWA7 NEU1 BRD8 TRPM3 CNTN5 DLEC1 | 1.54e-03 | 755 | 148 | 11 | EFO_0007984 |
| Disease | creatinine measurement | DENND5B CYP1A1 GAPVD1 LAMA2 LAMA5 IDI2 LCP1 SLC6A13 CILP2 NRXN2 LRP2 DLEC1 ARHGEF26 | 1.56e-03 | 995 | 148 | 13 | EFO_0004518 |
| Disease | triacylglycerol 58:12 measurement | 1.60e-03 | 12 | 148 | 2 | EFO_0010439 | |
| Disease | Cardiomyopathy | 1.71e-03 | 47 | 148 | 3 | cv:C0878544 | |
| Disease | hyperglycemia (is_marker_for) | 1.88e-03 | 13 | 148 | 2 | DOID:4195 (is_marker_for) | |
| Disease | Retinitis Pigmentosa | 1.89e-03 | 104 | 148 | 4 | C0035334 | |
| Disease | total brain volume change measurement | 2.19e-03 | 14 | 148 | 2 | EFO_0021504 | |
| Disease | revision of total hip arthroplasty | 2.19e-03 | 14 | 148 | 2 | EFO_0020973 | |
| Disease | anemia (implicated_via_orthology) | 2.51e-03 | 15 | 148 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | isoleucine measurement | 2.82e-03 | 56 | 148 | 3 | EFO_0009793 | |
| Disease | Rolandic epilepsy | 2.86e-03 | 16 | 148 | 2 | Orphanet_1945 | |
| Disease | heart disease (biomarker_via_orthology) | 3.23e-03 | 17 | 148 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | CYP1A1 KALRN SPTLC2 NICN1 TIGD4 CDH23 LCP1 ABCA7 VSTM4 CILP2 CNTN5 ADGRD2 CDH1 ATP2B3 MAST3 | 3.24e-03 | 1347 | 148 | 15 | EFO_0005192 |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 3.63e-03 | 18 | 148 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | Sjogren's syndrome (is_implicated_in) | 3.63e-03 | 18 | 148 | 2 | DOID:12894 (is_implicated_in) | |
| Disease | Cardiomyopathies | 4.23e-03 | 130 | 148 | 4 | C0878544 | |
| Disease | hearing loss | 4.68e-03 | 67 | 148 | 3 | EFO_0004238 | |
| Disease | eye colour measurement | 4.95e-03 | 218 | 148 | 5 | EFO_0009764 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IPQVVEPIGVALESG | 611 | Q68DN1 | |
| ILEPLIGDLPFVGAV | 246 | Q9BSJ8 | |
| DVFPTVVQLVGGEVP | 416 | P51689 | |
| VALVPEDIPAGSIIF | 141 | Q96JP9 | |
| NIPAVEAPVVADGVG | 186 | O00478 | |
| VGVAPTGIPAAVEGI | 386 | Q13363 | |
| GDEVPVQGVAITFEP | 116 | Q02641 | |
| LPVVPITGEALVGFL | 1566 | P78363 | |
| NIPTVEAPVVADGVG | 186 | O00481 | |
| EPVISGAEIVAGVVP | 516 | Q9H0E9 | |
| PLEGFGEVPEIIPIF | 2001 | Q86TB3 | |
| VIVVFSSGPDLEPLI | 266 | P41180 | |
| PGLIPDADAVGVTVV | 81 | Q9Y294 | |
| LPGEFVSEALLVPEG | 141 | P51693 | |
| IDVTLPTGEVTVPGV | 451 | Q09666 | |
| LTGPSVGVEVPDVEL | 1951 | Q09666 | |
| FPVEDGGTLLAAQIP | 51 | Q96DR7 | |
| ADAPGVIPGIVGAVV | 121 | P14209 | |
| IPAIVTGLAVGLDPQ | 2581 | Q9NYQ6 | |
| TPFPVLLFGGDIEVQ | 1291 | Q7Z478 | |
| GDPLGEFVISPVEGV | 1786 | Q9H251 | |
| VPGDIVEVAVGDKVP | 146 | O14983 | |
| TPGEVIPVFAEIDNG | 196 | Q8TBH0 | |
| VPGDIVEVAVGDKVP | 146 | Q93084 | |
| GVTVLVVAVPEGLPL | 421 | Q16720 | |
| IGVSLAVAAIPEGLP | 326 | O75185 | |
| FTSLVAGINPVVPGE | 1601 | Q2TAZ0 | |
| VGDPAVVFLDEPTTG | 1941 | Q8IZY2 | |
| AVVPLPDAGVYIIEV | 1031 | O94779 | |
| VVLEPPVLSGEDDGV | 281 | Q6UXK2 | |
| TGPESDPVVIVRFLG | 441 | Q9ULI1 | |
| TVSLGGFEITPPVVL | 86 | P06748 | |
| PSEFDVIVIGTGLPE | 6 | P24386 | |
| PTEFDVVIIGTGLPE | 6 | P26374 | |
| LSIPLGVEFVVPRTG | 1146 | Q5T481 | |
| LPELPGEYVITVTGE | 1311 | P20742 | |
| GGIIYDVIVEPPSVG | 46 | Q9NRP0 | |
| LVTIEPAGSVPALGV | 2421 | P98160 | |
| LEFVGPVPTERLEQG | 621 | Q7Z6P3 | |
| FGPEAAAGLVPLVVR | 46 | Q96NA2 | |
| EVVGSGNPADFIPIL | 226 | P04798 | |
| GPDIIPIVAGVVAGI | 726 | P05556 | |
| PAVEIPEEGFLLGCV | 596 | Q6ZW49 | |
| PGDELVYVDGIPVAG | 821 | Q86UL8 | |
| PGVEDAPIAKVGVLA | 491 | Q9UHB6 | |
| VSVPVGDVVVVPTEG | 6 | Q9Y692 | |
| GALGTRPAFEVPAIV | 231 | Q16538 | |
| SPFVPIGIAGFVTVV | 26 | A8MV81 | |
| LIERGFVPDTPVGVA | 546 | Q6DN90 | |
| VCGVVEGLSPTELPF | 336 | Q9UNE0 | |
| VPGADDFVPVLVFVL | 1416 | Q14C86 | |
| AGVPVAAAVEPGEVT | 41 | Q5T2Q4 | |
| EEVQGPGVVGEFPII | 341 | Q9UK99 | |
| VAPKGDEEGVPAVVI | 306 | P13796 | |
| ELEIQAPPGTIVGYV | 151 | A0PG75 | |
| PSAFILIGIPGLESV | 11 | Q9H2C5 | |
| PDSEIVFPLDIGVVG | 126 | P35913 | |
| GFTPEELHAILGVQP | 451 | P15036 | |
| TVLGSPVPVNVFLGV | 46 | Q6NT32 | |
| LDTIPVFQRGGSVIP | 766 | Q8TET4 | |
| FAAPEVIQGIPVSLG | 2846 | O60229 | |
| VASDLFVGGIPPDVR | 146 | Q9P2S2 | |
| DVTLVPGDGDEIFPV | 51 | Q9P2J3 | |
| SLEDIVVVLGPSVGP | 326 | Q8IV20 | |
| VTGPPRVADTVFLVG | 216 | A6NIK2 | |
| FVELSPVPIDVGTEI | 2536 | P24043 | |
| TALGVGFPIGITVDP | 1866 | P98164 | |
| GVTLVPIEEFSPEFV | 1186 | O15230 | |
| FSGLEIVPNGITLPV | 131 | P31943 | |
| IEGFVIQEGLEPFPV | 706 | Q8NDX5 | |
| VFGPELVSLGPEEQF | 481 | Q14764 | |
| PSPEGTFDAVLIVGA | 126 | Q8N6F8 | |
| VAPQGLERVPGIFIS | 181 | Q9NPB6 | |
| IFELLGGITSPAEIP | 486 | Q99575 | |
| VGVFPSLLVEELLGP | 596 | Q86WN1 | |
| VPGDIVEIAVGDKVP | 146 | P16615 | |
| LGIPGEQISPEDIVF | 116 | Q9BXS1 | |
| IFEIQPISGVLDPGE | 1766 | Q4G0P3 | |
| VPLFQGIISDLFPGV | 1646 | Q8TD57 | |
| QEVIRPGATGIPEFD | 1221 | O00512 | |
| IPHGDTDAIPVTFIG | 531 | O75128 | |
| LSEVLVQFGIPPEGS | 396 | Q6ZUT9 | |
| PTIAFATIPAAGGVI | 571 | P85037 | |
| NIPAVEAPVVADGVG | 186 | P78410 | |
| IVVGPTDPILATVGE | 31 | Q7KYR7 | |
| SVSDVPKGVLGFPVV | 2186 | Q99698 | |
| IAVEGEEAVPVALGP | 1291 | O60307 | |
| LADVLSAPVPFIVGI | 461 | O75064 | |
| GSVDEEIFGVPIPIV | 256 | Q6ZS86 | |
| EIFGVPIPIVALVAD | 261 | Q6ZS86 | |
| PTETFIPVIRGLVGN | 1596 | Q9H583 | |
| GLAPVPNGVDVDEFI | 711 | P55286 | |
| GIGVPSVEFLESPIT | 211 | A4D161 | |
| IATVGFVEQPPFGIL | 526 | Q9Y238 | |
| GEIGPFSSIKVPIVF | 751 | Q9C0B2 | |
| GADTPPVGVFIIERE | 196 | P12830 | |
| EEIAGVGVPELINSP | 1201 | Q9BXW9 | |
| LVGVEQDPGISVVPG | 176 | O43193 | |
| APVGGGAFPTIVERE | 396 | Q15084 | |
| LLGVGPQVEEFSVEP | 556 | Q7Z6I6 | |
| REPVFVGGVPESLLT | 1766 | Q16363 | |
| PSTFLVVGVPGLEDV | 11 | Q8NH55 | |
| FSGLEIVPNGITLPV | 131 | P52597 | |
| VILVIAPVGSPGDEF | 281 | Q96FC7 | |
| FALSEIEVIPGGELP | 71 | Q5HYW3 | |
| LFGVLDRVPDGPVFI | 116 | Q6NT16 | |
| LVVVDTPGIFDTEVP | 81 | Q9NUV9 | |
| LVPDDIVIPGGVNAT | 151 | P58743 | |
| EPSTGGELVIPLLVE | 326 | Q9HDB5 | |
| DTIIVPGVEGPIVTQ | 886 | O60841 | |
| GRPGVLVIDVTFPSV | 26 | Q9BSH3 | |
| PELVDPVVAAGAVVT | 311 | Q99519 | |
| PISEVAESGPGLAFI | 351 | P48065 | |
| ALGEEVLGPLAQVVP | 416 | Q8N196 | |
| EGEAVVLPEVEPGLT | 101 | P18827 | |
| LPLVEVVVPTGAAGN | 251 | Q86YJ6 | |
| LSASPEVVVAVGFPG | 361 | Q96T60 | |
| TLGPQVAPVAAGEVV | 36 | Q7Z7M1 | |
| PIVSPLLGSIAGVFV | 246 | Q92482 | |
| EGVVVTLVNLEPAPG | 756 | Q8IUL8 | |
| GYEGIVVAIDPNVPE | 31 | A8K7I4 | |
| ITIGGLPEPQTLFEI | 406 | Q9NQW8 | |
| VAVPVVEAVPEEGLA | 1266 | O15417 | |
| SVVFSGGPVPDLVLK | 861 | Q14690 | |
| EPEPGFEVISCVELG | 256 | Q9HA65 | |
| TAAGVVAVVVPVPAG | 21 | Q9Y2T7 | |
| TEFEGLVPEPGVRVF | 526 | Q9H2B4 | |
| APGDVVAIFLEGRPE | 126 | Q6PCB7 | |
| IGVVVVGFPATPIIE | 491 | O15270 | |
| PVVALIVEGGPNVIS | 356 | Q9HCF6 | |
| IQVHTFPEGVPDGIL | 76 | O75717 | |
| VFVGGAVSSPLVAPD | 16 | Q8IUW5 | |
| PTVGVDLALPGAEVE | 331 | Q9BXM0 | |
| SPGNVVVAVGEPAVL | 171 | Q96MS0 | |
| GIDEFLDQVTVLPPG | 416 | Q6U841 | |
| PISEVAESGPGLAFI | 346 | Q9NSD5 | |
| PGIPAAEVGIGVVAE | 916 | P18206 | |
| GLVFRAQPVEATGVP | 141 | Q8IY51 | |
| LVVDAVLGPGVEPGE | 191 | A6XGL0 | |
| ELVAIVESPLGPVGL | 16 | Q8IZM8 | |
| PIAEVAESGPGLAFI | 366 | P48066 | |
| LGGVTEVPVPTRFLF | 331 | Q9BY07 | |
| DQTDFPVRVLVGGEP | 296 | Q86WI1 | |
| GATVLGLFRVTPEIP | 231 | P41273 | |
| EPVLVVSFVVGGLAV | 16 | O95167 | |
| VSFVVGGLAVILPPL | 21 | O95167 | |
| ETGVSIIIPQGAIPE | 1651 | Q07157 | |
| FITVAPEGKAGPILT | 3361 | Q7Z7G8 | |
| PEIFTEIGTIAAGIP | 1651 | A6NGW2 | |
| VTVSPGPVVDYLEGE | 26 | Q8IW00 | |
| TSIPLFVDGVLGEPG | 626 | Q8WY21 | |
| ETLGGFPVKSVVPAL | 471 | Q14669 | |
| EPGEGPVLLVTVVTG | 56 | A0A087WT01 | |
| VVPGQPLVFSVDGLL | 511 | Q9Y334 | |
| RAIAIAAGVPVVPGT | 156 | P11498 | |
| EIEGEGLQTVVPTPI | 96 | Q8WW01 | |
| EIPALPVFGDGTNVI | 236 | Q96M32 |